摘要
目的:探讨急性冠脉综合征(acute coronary syndrome,ACS)患者发病早期外周血可溶性血管内皮生长因子受体1(soluble fms-like tyrosine kinase receptor 1,sFlt-1)水平的变化及临床意义。方法:选取150例在胸痛、胸闷6 h内就诊的患者,根据最终临床诊断其中102例ACS患者入选ACS组,48例排除ACS的患者入选对照组;比较两组患者入院即刻外周血sFlt-1水平,并绘制受试者工作特征(ROC)曲线,计算曲线下面积,分析血浆sFlt-1水平对ACS的诊断效能。结果:ACS患者发病早期的血浆sFlt-1水平(361.7±288.0)pg/m L显著高于对照组[(126.2±49.6)pg/m L,P<0.01];入院即刻采用sFlt-1单点值诊断ACS的ROC曲线下面积为0.852。结论:血浆sFlt-1在ACS发生的早期显著升高,早期检测sFlt-1有助于ACS患者的早期诊治。
Objective: To explore the clinical values of the peripheral soluble fms-like tyrosine kinase receptor 1 (sFlt-1) levels in early acute coronary syndrome(ACS) patients. Methods: A total of 150 patients who were admitted to hospital in six hours after chest pain occurred were recruited and divided into control group (n =48) or acute coronary syndrome group( ACS, n = 102), plasma sFh-1 were detected and compared between the two groups. Receiver operating characteristic (ROC) curve and area under curve (AUC) were analysed with SPSS 20.0 statistical software. Results: The levels of plasma sFlt-1 in ACS group were significantly higher compared with that of the control group [ ( 361. 7 ± 288.0 ) pg/mL vs ( 126.2± 49.6) pg/mL,P 〈 0.01] For the diagnosis of ACS, the AUC of sFlt-1 was 0. 852. Conclusion : Plasma sFh-1 was significantly elevated in the early ACS patients, and it could be one of the earliest sensitive indicators in the diagnosis and risk estimation of ACS.
出处
《江苏大学学报(医学版)》
CAS
2017年第1期58-60,共3页
Journal of Jiangsu University:Medicine Edition
基金
南京医科大学科技发展基金资助项目(2013njmu154)
无锡市医管中心资助项目(YGZXM1517)